{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:57:50Z","timestamp":1783727870805,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["U1C\/W41\/NO\/28.23"],"award-info":[{"award-number":["U1C\/W41\/NO\/28.23"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"crossref","award":["SZPITALE-JEDNOIMIENNE\/18\/2020"],"award-info":[{"award-number":["SZPITALE-JEDNOIMIENNE\/18\/2020"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Healthcare-associated infections (HAI) and bacterial antimicrobial resistance posed a therapeutic risk during the coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to analyze the HAIs in COVID-19 patients in the Intensive Care Unit (ICU) and non-ICU at the University Hospital in Krakow (UHK) with an emphasis on the susceptibility of the most frequently isolated pathogens and the prevalence of extensively drug resistant (XDR) microorganisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This laboratory-based study was carried out at the University Hospital in Krakow in the ICU and non-ICUs dedicated to COVID-19 patients between May 2021 and January 2022. All isolates of\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      were analyzed using PFGE protocol.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      292 independent HAI cases were identified, with the predominance of urinary tract infections (UTI), especially in the non-ICU setting. The most common ICU syndrome was pneumonia (PNA). The prevalence of XDR organisms was 22.6% in the ICU and 14.8% in non-ICUs among all isolates. The incidence of carbapenem-resistant Enterobacteriaceae infection was 24.8 cases per 10,000 hospitalizations and the carbapenem-resistant\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      infection incidence was 208.8 cases per 10,000 hospitalizations. The prevalence of XDR strains was highest in\n                      <jats:italic>Acinetobacter spp<\/jats:italic>\n                      , in PNA cases. The PFGE typing demonstrated that almost all XDR strains varied widely from each other.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this study, there was a high incidence of HAI in COVID-19 patients, especially when compared to Western Europe and the United States. Similarly, the prevalence of XDR microorganisms, especially XDR-\n                      <jats:italic>A.baumannii<\/jats:italic>\n                      , was also high. PFGE did not confirm the horizontal spread of any organism strains.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-023-00625-8","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T14:03:02Z","timestamp":1692885782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Secondary bacterial infections &amp; extensively drug-resistant bacteria among COVID-19 hospitalized patients at the University Hospital in Krak\u00f3w"],"prefix":"10.1186","volume":"22","author":[{"given":"A","family":"Pa\u0142ka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kujawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DA","family":"Hareza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Wordliczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Jachowicz-Matczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Owsianka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"\u017b\u00f3\u0142towska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chmielarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Romaniszyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorczyk-Maga","family":"I","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"W\u00f3jkowska-Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"issue":"10325","key":"625_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"issue":"9","key":"625_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10096-018-3300-0","volume":"37","author":"C Abat","year":"2018","unstructured":"Abat C, Fournier PE, Jimeno MT, et al. Extremely and pandrug-resistant bacteria extra-deaths: myth or reality? Eur J Clin Microbiol Infect Dis. 2018;37(9):1687\u201397. https:\/\/doi.org\/10.1007\/s10096-018-3300-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"15","key":"625_CR3","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","volume":"22","author":"A Alexopoulou","year":"2016","unstructured":"Alexopoulou A, Vasilieva L, Agiasotelli D, et al. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol. 2016;22(15):4049\u201356. https:\/\/doi.org\/10.3748\/wjg.v22.i15.4049.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"625_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41426-018-0038-9","volume":"7","author":"R Xie","year":"2018","unstructured":"Xie R, Zhang XD, et al. Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries. Emerg Microbes Infect. 2018;7(1):31. https:\/\/doi.org\/10.1038\/s41426-018-0038-9.","journal-title":"Emerg Microbes Infect"},{"key":"625_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2147\/IDR.S166750","volume":"11","author":"M Asif","year":"2018","unstructured":"Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249\u201360. https:\/\/doi.org\/10.2147\/IDR.S166750.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"625_CR6","doi-asserted-by":"publisher","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","volume":"3","author":"M Castanheira","year":"2021","unstructured":"Castanheira M, Simner PJ, Bradford PA. Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist. 2021;3(3):dlab092. https:\/\/doi.org\/10.1093\/jacamr\/dlab092.","journal-title":"JAC Antimicrob Resist"},{"issue":"2","key":"625_CR7","doi-asserted-by":"publisher","first-page":"e01951","DOI":"10.1128\/AAC.01951-19","volume":"64","author":"M Castanheira","year":"2020","unstructured":"Castanheira M, Doyle TB, Kantro V, et al. Meropenem-Vaborbactam activity against Carbapenem-Resistant Enterobacterales isolates collected in U.S. hospitals during 2016 to 2018. Antimicrob Agents Chemother. 2020;64(2):e01951\u201319. https:\/\/doi.org\/10.1128\/AAC.01951-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"625_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1128\/CMR.00047-19","volume":"33","author":"K Bush","year":"2020","unstructured":"Bush K, Bradford PA. Epidemiology of \u03b2-lactamase-producing pathogens. Clin Microbiol Rev. 2020;33(2):47.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"625_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","volume":"17","author":"H Grundmann","year":"2017","unstructured":"Grundmann H, Glasner C, Albiger B, et al. European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the european survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153\u201363. https:\/\/doi.org\/10.1016\/S1473-3099(16)30257-2.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"625_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, et al. Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366. https:\/\/doi.org\/10.1016\/S1473-3099(18)30605-4.","journal-title":"Lancet Infect Dis"},{"key":"625_CR11","unstructured":"Download historical data (to 20. june 2022) on the weekly number of new reported COVID-19 cases and deaths worldwide. European Centre for Disease Prevention and Control; 2022."},{"issue":"12","key":"625_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ajic.2020.09.015","volume":"48","author":"E Farfour","year":"2020","unstructured":"Farfour E, Lecuru M, Dortet L, et al. SARS-CoV-2 Hospital Foch study group. Carbapenemase-producing Enterobacterales outbreak: another dark side of COVID-19. Am J Infect Control. 2020;48(12):1533\u20136. https:\/\/doi.org\/10.1016\/j.ajic.2020.09.015.","journal-title":"Am J Infect Control"},{"issue":"1","key":"625_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13756-022-01085-z","volume":"11","author":"RM Kariyawasam","year":"2022","unstructured":"Kariyawasam RM, Julien DA, Jelinski DC, et al. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021). Antimicrob Resist Infect Control. 2022;11(1):45. https:\/\/doi.org\/10.1186\/s13756-022-01085-z.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"625_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/INF.0b013e318287fe2a","volume":"32","author":"J W\u00f3jkowska-Mach","year":"2013","unstructured":"W\u00f3jkowska-Mach J, Chmielarczyk A, Borszewska-Kornacka M, et al. Enterobacteriaceae infections of very low birth weight infants in polish neonatal intensive care units: resistance and cross-transmission. Pediatr Infect Dis J. 2013;32(6):594\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"625_CR15","unstructured":"European Centre for Disease Prevention and Control. Healthcare-associated infections acquired in intensive care units. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC. ; 2019 https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2017-HAI.pdf Accessed July, 2022."},{"issue":"1","key":"625_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03885-y","volume":"26","author":"A Conway Morris","year":"2022","unstructured":"Conway Morris A, Kohler K, De Corte T, et al. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022;26(1):1\u201313.","journal-title":"Crit Care"},{"key":"625_CR17","unstructured":"Antimicrobial resistance surveillance in Europe., 2022. ECDC Web site. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Joint-WHO-ECDC-AMR-report-2022.pdf. Updated 2022. Accessed July 2022."},{"key":"625_CR18","unstructured":"Surveillance atlas of infectious diseases. ECDC Web site. https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx?Dataset=27&HealthTopic=4. Updated 2020. Accessed Sept 30, 2022."},{"key":"625_CR19","unstructured":"Antimicrobial resistance in the EU\/EEA (EARS-net.) - annual epidemiological report for 2020. European Centre for Disease Prevention and Control Web site. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2020. Updated 2022. Accessed Sep 30, 2022."},{"issue":"46","key":"625_CR20","doi-asserted-by":"publisher","first-page":"1800516","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516","volume":"23","author":"C Suetens","year":"2018","unstructured":"Suetens C, Latour K, K\u00e4rki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two european point prevalence surveys, 2016 to 2017. Eurosurveillance. 2018;23(46):1800516.","journal-title":"Eurosurveillance"},{"issue":"14","key":"625_CR21","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","volume":"382","author":"JA Jernigan","year":"2020","unstructured":"Jernigan JA, Hatfield KM, Wolford H, et al. Multidrug-resistant bacterial infections in US hospitalized patients, 2012\u20132017. N Engl J Med. 2020;382(14):1309\u201319.","journal-title":"N Engl J Med"},{"issue":"10","key":"625_CR22","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1128\/AAC.01707-09","volume":"54","author":"CA DeRyke","year":"2010","unstructured":"DeRyke CA, Crawford AJ, Uddin N, Wallace MR. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother. 2010;54(10):4503\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"625_CR23","doi-asserted-by":"publisher","first-page":"dlab060","DOI":"10.1093\/jacamr\/dlab060","volume":"3","author":"WR Truong","year":"2021","unstructured":"Truong WR, Hidayat L, Bolaris MA, Nguyen L, Yamaki J. The antibiogram: key considerations for its development and utilization. JAC-Antimicrobial Resist. 2021;3(2):dlab060.","journal-title":"JAC-Antimicrobial Resist"},{"issue":"3","key":"625_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1086\/658665","volume":"32","author":"JM Pogue","year":"2011","unstructured":"Pogue JM, Alaniz C, Carver PL, Pleva M, Newton D, DePestel DD. Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Infect Control Hosp Epidemiol. 2011;32(3):289\u201392. https:\/\/doi.org\/10.1086\/658665.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"625_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-018-0428-8","volume":"7","author":"J Wojkowska-Mach","year":"2018","unstructured":"Wojkowska-Mach J, Godman B, Glassman A, et al. Antibiotic consumption, and antimicrobial resistance in Poland; findings and implications. Antimicrob Resist Infect Control. 2018;7(1):1\u201310.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"625_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520\u201331. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.018.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"625_CR27","doi-asserted-by":"publisher","first-page":"e1453","DOI":"10.1016\/S2214-109X(20)30444-7","volume":"8","author":"AS Ginsburg","year":"2020","unstructured":"Ginsburg AS, Klugman KP. COVID-19 pneumonia and the appropriate use of antibiotics. Lancet Glob Health. 2020;8(12):e1453\u20134. https:\/\/doi.org\/10.1016\/S2214-109X(20)30444-7.","journal-title":"Lancet Glob Health"},{"issue":"10","key":"625_CR28","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62(10):e51\u2013e77.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"625_CR29","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/jac\/dkr370","volume":"66","author":"M Dryden","year":"2011","unstructured":"Dryden M, Johnson AP, Ashiru-Oredope D, Sharland M. Using antibiotics responsibly: right drug, right time, right dose, right duration. J Antimicrob Chemother. 2011;66(11):2441\u20133.","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"625_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMe2002375","volume":"382","author":"FC Fang","year":"2020","unstructured":"Fang FC, Schooley RT. Antimicrobial resistance\u2014the glass is half full. N Engl J Med. 2020;382(14):1363\u20135.","journal-title":"N Engl J Med"},{"key":"625_CR31","unstructured":"Centers for Disease Control. and Prevention Antibiotic use in the United States, 2018 update: Progress and opportunities. CDC. 2019."},{"issue":"4","key":"625_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3201\/eid2704.204036","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel A, Emerick M, Cabunoc MK, et al. Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 patient care units. Emerg Infect Dis. 2021;27(4):1234\u20137. https:\/\/doi.org\/10.3201\/eid2704.204036.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"625_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5604\/01.3001.0010.4856","volume":"66","author":"B Mazi\u0144ska","year":"2017","unstructured":"Mazi\u0144ska B, Hryniewicz W. Polish Physicians\u2019 Attitudes towards antibiotic prescription and Antimicrobial Resistance. Pol J Microbiol. 2017;66(3):309\u201319. https:\/\/doi.org\/10.5604\/01.3001.0010.4856.","journal-title":"Pol J Microbiol"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00625-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T10:19:25Z","timestamp":1700216365000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00625-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00625-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2428958\/v1","asserted-by":"object"}]},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was waived by the Bioethics Committee of Jagiellonian University (approval no1072.6120.353.2020 from 16.12.2020). in view of the retrospective nature of the study and all the procedures being performed were part of routine care. All data analyzed during this study was anonymized prior to analysis. The study was based on the laboratory data gathered during routine patients\u2019 care and the analyzing did not include any individual participant\u2019s data. As a result, no statements on consent from participants were required. The study in this form was approved by the local Bioethics Committee of Jagiellonian University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"77"}}